While these studies do not yet provide convincing evidence for Bmi-1 serving as a possible way to prognosticate treatment response, Bmi-1 is undoubtedly an important master regulator of cancer cell stemness and therapeutic resistance, rendering it a putative therapeutic target, nonetheless. Here, BMI1 is linked to cancer.